REVEALED: 7 | Vintage Vibes

RBC Capital Cuts Hudbay Minerals Price Target By 14%

RBC Capital analyst Sam Crittenden lowered the price target for HudBay Minerals Inc (TSX:HBM) (NYSE:HBM) to C$12 from C$14. The analyst maintained the Outperform rating on the shares. Crittenden stated that, despite what should be the year's weakest quarter, he continues to expect strong FCF and production growth from Hudbay in 2022. The analyst believes…

Benzinga · May 11, 2022

What's Going On With Keyera Shares Today

Keyera Corp (TSX:KEY) (OTC:KEYUF) price target was raised to C$37 from C$35 by RBC Capital analyst Robert Kwan. The risk-adjusted expected total return to price target supports Outperform rating for the shares. With the recent Investor Day in March, the analyst viewed most of the quarterly updates as incremental, although noted the increase in guidance…

Benzinga · May 11, 2022

RBC Capital Trims Melcor Developments Price Target By 5%

Melcor Developments Ltd. (TSX:MRD) (OTC:MODVF) price target has been lowered to C$18 from C$19 by RBC Capital analyst Tom Callaghan. The analyst maintained the Sector Perform rating on the shares. Callaghan states that there is no change in constructive stance on Melcor Developments following Q1 results. The analyst continues to see several tailwinds in both…

Benzinga · May 11, 2022

RBC Capital Boosts Ensign Energy Services Price Target By 8%

Ensign Energy Services Inc (TSX:ESI) (OTC:ESVIF) price target has been raised to C$6.50 from C$6 by RBC Capital analyst Keith Mackey. The analyst maintained the Outperform, Speculative Risk rating on the shares. Mackey stated that Ensign's 1Q22 results were in line with estimates, and the company modestly improved its financial liquidity through the disposition of…

Benzinga · May 10, 2022

What Are Whales Doing With Palantir Technologies

Someone with a lot of money to spend has taken a bearish stance on Palantir Technologies (NYSE:PLTR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · May 10, 2022

RBC Capital Maintains Outperform Rating for ADC Therapeutics: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of ADC Therapeutics (NYSE:ADCT) and lower its price target from $34.00 to $30.00. Shares of ADC Therapeutics are trading down 1.34% over the last 24 hours, at $7.71 per share.

Benzinga · May 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022

Upgrades

Benzinga · May 10, 2022

RBC Capital Slashes IGM Financial Price Target By 11%

RBC Capital analyst Geoffrey Kwan lowered the price target for IGM Financial Inc. (TSX:IGM) (OTC:IGIFF) to C$47 from C$53 while maintaining the Sector Perform rating on the shares. Kwan notes the reduced target reflects lower financial forecasts given the significant decline in equity markets since the last report. Kwan believes IGM is delivering the best…

Benzinga · May 9, 2022

What's Going On With Chorus Aviation Shares Today

Chorus Aviation Inc (TSX:CHR) (OTC:CHRRF) price target was raised to C$5 from C$4.75 by RBC Capital analyst Walter Spracklin. The analyst maintained the Outperform rating on the shares. Spracklin says, while Q1 was mixed, management provided solid new guidance on the back of the Falko acquisition. The analyst adds that the acquisition created the "world's…

Benzinga · May 9, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga · May 6, 2022